Revenue (2022)$85.2B6.5%(2022 vs 2021) EPSXYZ Net Income (2022)XYZ95.9%(2022 vs 2021) Market Cap*$402.0B Net Profit Margin (2022)XYZ84.0%(2022 vs 2021) * As ofand is in US$ View Johnson & Johnson financials Johnson & Johnson premium industry data and analytics ...
LINDA A. JOHNSON, AP Business Writer
Adjusting for COVID-19 vaccine costs - which were quite pronounced in 2022 ($1.5 billion) and 2023 ($663 million) - is incomprehensible to me. For example, if we take JNJ's 2023 pre-tax income from continuing operations of $15.1 billion and divide it by the stated margin of 17.7%...
Find the latest Johnson & Johnson Common Stock (JNJ) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.
Johnson & Johnson company earnings calendar and analyst expectations - Upcoming and past events | Nyse: JNJ | Nyse
TheMotley Fool Stock Advisoranalyst team just identified what they believe are the10 best stocksfor investors to buy now… and Johnson & Johnson wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. ...
Johnson & Johnson's R&D expenses were about $3.83 billion in Q2, or 15% of total revenue, up slightly from the previous year. We estimate that the company's 2023 medicine and vaccine development spending will remain at its 2022 level, partly due to concerns about...
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%),...
Headquarters: 1 Johnson And Johnson Plaza, New Brunswick, NJ 08901 Website: http://www.jjmt.com.tw/ Employees: 130000 Johnson & Johnson - Operating Industries and Main Competitors pie_chart OD4125 - Acne Treatment Manufacturing OTC Johnson & Johnson Market Share: x.x%lock Reckitt Benckiser Gr...
2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0%* and adjusted operational growth of 7.6%* 2023 First-Quarter basic loss per share of ($0.03) decreasing 101.6% due to a special one-time charge, with adjust